NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ALBT

Avalon GloboCare Corp

Jul 03 • 03:25PM ET

2.68

Dollar change -0.11
Percentage change -3.94	%

Real Estate • Real Estate Services • USA • NASD

Peers: AAPL GOOGL MSFT AMZN NFLX TSLA NVDA ADBE CRM PYPL

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-33.61	Insider Own	61.27%	Shs Outstand	1.65M	Perf Week	-22.54%
Market Cap	5.71M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.83M	Perf Month	-23.43%
Enterprise Value	24.94M	PEG	-	EPS next Q	-	Inst Own	0.79%	Short Float	0.77%	Perf Quarter	-44.17%
Income	-9.02M	P/S	4.17	EPS this Y	-	Inst Trans	0.37%	Short Ratio	0.10	Perf Half Y	-21.87%
Sales	1.37M	P/B	-	EPS next Y	-	ROA	-58.29%	Short Interest	0.01M	Perf YTD	-17.79%
Book/sh	-9.83	P/C	4.17	EPS next 5Y	-	ROE	-833.99%	52W High	12.60 -78.73%	Perf Year	-61.53%
Cash/sh	0.64	P/FCF	-	EPS past 3/5Y	19.31% 25.22%	ROIC	-	52W Low	2.11 27.01%	Perf 3Y	-96.12%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-1.40% -2.92%	Gross Margin	20.88%	Volatility	10.68% 9.26%	Perf 5Y	-99.05%
Dividend TTM	-	EV/Sales	18.20	EPS Y/Y TTM	-59.27%	Oper. Margin	-389.45%	ATR (14)	0.30	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.19	Sales Y/Y TTM	7.42%	Profit Margin	-658.91%	RSI (14)	37.20	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.19	EPS Q/Q	17.86%	SMA20	-11.41%	Beta	-0.01	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	11.19%	SMA50	-22.00%	Rel Volume	0.33	Prev Close	2.79
Employees	5	LT Debt/Eq	-	Earnings	-	SMA200	-30.00%	Avg Volume	62.92K	Price	2.68
IPO	Dec 06, 2016	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	20,538	Change	-3.94%

Jun-26-25 08:00AM	Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving (GlobeNewswire)
Apr-29-25 08:00AM	Avalon GloboCare Advances Proposed Merger with YOOV with Filing of Registration Statement (GlobeNewswire) -7.65%
Apr-15-25 08:00AM	Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs' Fitness Challenge with KetoAir (GlobeNewswire)
Apr-10-25 08:00AM	Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China (GlobeNewswire) -6.50%
Apr-01-25 09:00AM	Avalon GloboCare Partners with Pounds Transformation Clinics to Unveil the KetoAir BrAce 4 Impact Challenge Series (GlobeNewswire)
08:00AM	Loading…
Mar-10-25 08:00AM	Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement (GlobeNewswire) -24.07%
Feb-27-25 08:00AM	Fusion Fuel Appoints Luisa Ingargiola to Board of Directors (GlobeNewswire) -11.16%
Feb-18-25 09:00AM	Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China (GlobeNewswire) +13.01%
Nov-21-24 09:00AM	Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements (GlobeNewswire)
Nov-18-24 09:00AM	Avalon GloboCare Launches BrAce for Impact' Affiliate Marketing Program for the KetoAir Breathalyzer Device (GlobeNewswire) -13.97%
Oct-31-24 09:00AM	Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales (GlobeNewswire) -6.01%
Oct-25-24 09:00AM	Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving (GlobeNewswire) +13.75%
08:31AM	EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer (Benzinga)
Oct-24-24 09:00AM	Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan (GlobeNewswire)
Oct-09-24 09:00AM	Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device (GlobeNewswire) -6.74%
08:00AM	Loading…
Aug-14-24 08:00AM	Avalon's Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device (GlobeNewswire) +87.53%
07:30AM	EXCLUSIVE: Avalon's Lab Services MSO Poised To Commercialize FDA-Registered External Male Catheter Device (Benzinga)
Jul-31-24 08:00AM	Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction (GlobeNewswire) -14.31%
Jul-18-24 09:00AM	Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us (GlobeNewswire)
Jun-21-24 07:30AM	7 F-Rated Penny Stocks to Avoid This June (InvestorPlace) +9.11%
Jun-20-24 08:30AM	Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference (GlobeNewswire)
Jun-04-24 11:00AM	Paramount Layoffs 2024: What to Know About the Latest PARA Job Cuts (InvestorPlace) -30.60%
08:55AM	Why Is Avalon Globocare (ALBT) Stock Down 27% Today? (InvestorPlace)
07:28AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jun-03-24 02:53PM	ALBT Stock Earnings: Avalon Globocare Reported Results for Q1 2024 (InvestorPlace) +316.95%
May-24-24 05:00PM	Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report (GlobeNewswire) +9.03%
May-21-24 08:30AM	La Rosa Appoints Corporate Finance Executive Lourdes Felix to its Board of Directors (GlobeNewswire) -5.78%
Apr-22-24 09:00AM	Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference (GlobeNewswire) -6.38%
Apr-16-24 09:52AM	ALBT Stock Earnings: Avalon Globocare Reported Results for Q4 2023 (InvestorPlace)
Mar-28-24 09:00AM	Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union (GlobeNewswire) +5.79%
09:00AM	Loading…
Dec-18-23 09:00AM	Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US (GlobeNewswire) +20.23%
Oct-18-23 09:00AM	Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis (GlobeNewswire) +22.65%
Oct-04-23 09:00AM	Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application (GlobeNewswire)
Sep-13-23 09:15AM	Avalons Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device (GlobeNewswire)
Sep-05-23 08:00AM	Avalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT) (GlobeNewswire) +27.00%
Aug-30-23 10:45AM	EXCLUSIVE: Diagnostics Provider Avalon GloboCare's Subsidiary Launches New Laboratory Test For Tuberculosis (Benzinga) +9.57%
09:00AM	Avalons Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis (GlobeNewswire)
Aug-21-23 09:00AM	Avalons Laboratory Services MSO Announces Expansion into Arizona (GlobeNewswire)
Jul-24-23 09:00AM	Avalons Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth (GlobeNewswire)
Jul-19-23 09:00AM	Avalon GloboCares Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States (GlobeNewswire) +11.36%
Jul-10-23 09:00AM	Avalon GloboCare Provides Update on New Commercial Strategy (GlobeNewswire)
Apr-27-23 09:00AM	Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022 (GlobeNewswire) +6.70%
Apr-17-23 09:00AM	Avalon GloboCare Announces Commercial Launch of KetoAir Breathalyzer at the KetoCon Austin 2023 Conference (GlobeNewswire)
Apr-11-23 09:00AM	Avalon GloboCare Signs Agreement with Qi Diagnostics to Exclusively Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, U.K. and European Union (GlobeNewswire) +17.98%
Mar-03-23 09:00AM	Avalon GloboCare to Participate in the 35th Annual Roth Conference (GlobeNewswire)
Feb-13-23 09:00AM	Avalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Company (GlobeNewswire) +16.99%
Jan-17-23 09:00AM	Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules (GlobeNewswire)
Jan-11-23 09:00AM	Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors (GlobeNewswire) -11.06%
Jan-03-23 09:00AM	Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology (GlobeNewswire) +7.69%
Dec-14-22 09:00AM	Avalon GloboCare Announces $4 Million Private Placement of Preferred Stock with the Companys Chairman which Converts at a Significant Premium to Market; Proceeds to Support Acquisition of Laboratory Services (GlobeNewswire) +10.58%
Dec-12-22 09:00AM	Avalon GloboCare Continues its U.S. Centric Strategy with a New Proposed Board Composition in Preparation for Acquisition of Laboratory Services MSO, LLC (GlobeNewswire) +18.78%

Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ALBT

Avalon GloboCare Corp

Upgrade your FINVIZ experience